Alkermes plc (ALKS)

Alkermes plc (ALKS) is a healthcare company (drug manufacturers - specialty & generic) based in Ireland. The share price is $45.38, down 2.47% on the day, which values the company at $7.63B. Price as of 17 Nov 2026, 17:23 UTC, from Yahoo Finance.

Key facts

Share price
$45.38−2.47% today
Market value
$7.63B
Forward P/E
33.5×
Funk Score
70/100
Against its own history
About its usual priceusual price $42.25
200-week average
$31.2445% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Alkermes plc in more detail

ALKS trades at 33.5× next year's expected earnings, 4.3× sales. Measured against its own history, the price is 7% above what its usual multiples would imply ($42.25) — about its usual price. It sits 45% above its 200-week average of $31.24.

Over the last five fiscal years Alkermes plc has compounded revenue 7.3% a year, free cash flow 63.9% a year. Its Funk Score is 70 out of 100 (financial strength 9.6, profitability 7.0, growth 6.0, value 5.3, each out of 10).

In its favour: Altman Z in the safe zone; Strong Piotroski score.

4 of the superinvestors tracked here hold ALKS, including Julian and Felix Baker (2.6% of the portfolio), Brandon Haley (0.4% of the portfolio), Jim Simons (1938–2024) (0.4% of the portfolio).

Superinvestors holding ALKS

4 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:ALKS vs PACS (Alkermes plc vs PACS Group)ALKS vs KNSA (Alkermes plc vs Kiniksa Pharmaceuticals International)ALKS vs IBRX (Alkermes plc vs ImmunityBio)ALKS vs CYTK (Alkermes plc vs Cytokinetics)ALKS vs ABVX (Alkermes plc vs ABIVAX)

All health care companies by market valueLargest companies in IrelandAll stocks A–Z

Alkermes plc (ALKS): questions and answers

What is ALKS's PEG ratio?

Alkermes plc's PEG ratio is 1.96 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is Alkermes plc's market cap?

Alkermes plc is valued at $7.63B at a share price of $45.38.

Is ALKS overvalued or undervalued?

Against its own history, ALKS is about its usual price: the price is 7% above the $42.25 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is ALKS above its 200-week moving average?

Yes. ALKS is 45.3% above its 200-week average of $31.24. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Alkermes plc growing?

Over the last five fiscal years Alkermes plc's revenue grew 7.3% a year; over ten years revenue grew 8.9% a year.

Does ALKS pay a dividend?

Alkermes plc does not currently pay a regular dividend.

Cite this page

Funkfolio, “Alkermes plc (ALKS) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/ALKS

Underlying data: Yahoo Finance; company filings with the SEC.